Director Patricia Ann Mosconi filed a Form 4 with the SEC on November 12, 2026, reporting the grant of 645 Deferred Stock Units and 2,659 stock options in Broadridge Financial Solutions, Inc. common stock on November 10, 2026.

Key Highlights

  • Reporting person: Patricia Ann Mosconi, identified in the filing as a Director of Broadridge Financial Solutions, Inc. (NYSE:BR).
  • DSU grant: 645 Deferred Stock Units were acquired on November 10, 2026, at a price of $0.0000, under Broadridge's 2018 Omnibus Award Plan.
  • Post-transaction common stock holdings: Mosconi directly holds 1,469 shares of common stock following the reported transaction.
  • Stock option grant: 2,659 stock options (right to buy) were granted on November 10, 2026, at an exercise price of $192.96, expiring November 10, 2036.
  • Vesting terms: Both the Deferred Stock Units and the stock options vest immediately upon grant, according to the filing.
  • DSU settlement: The Deferred Stock Units will settle in shares of Broadridge common stock upon the director's separation from service, as stated in the filing.

Broadridge Director Mosconi Granted DSUs and Stock Options on November 10, 2026

According to the Form 4 filed on November 12, 2026, Patricia Ann Mosconi, a Director of Broadridge Financial Solutions, Inc., received two separate equity grants on November 10, 2026. The first was an acquisition of 645 Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan, recorded at a price of $0.0000. The filing states these units "vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge." Following this transaction, Mosconi directly beneficially owns 1,469 shares of common stock.

The second grant consisted of 2,659 stock options (right to buy) in Broadridge common stock, also dated November 10, 2026, with an exercise price of $192.96 per share. The filing notes that these options are exercisable beginning November 10, 2026, and expire on November 10, 2036. The filing further states that "stock options vest immediately upon grant." After the transaction, Mosconi directly holds 2,659 derivative securities in this category.

Both grants are reported as acquisitions (transaction code A) and are held directly by the reporting person. The Form 4 was signed by Maria Allen under a Power of Attorney, and no amendment date was indicated, confirming this is an original filing.

What Was Disclosed

The filing disclosed two equity grants to Director Patricia Ann Mosconi on November 10, 2026: 645 Deferred Stock Units settling upon separation from service, and 2,659 immediately vesting stock options exercisable at $192.96 through November 10, 2036.